Ankle arthrodesis is the gold standard for treatment of end stage ankle arthritis. We analysed the data of 124 Ankle Arthrodesis (Open Ankle Arthrodesis (OAA) −27; Arthroscopic Ankle Arthrodesis (AAA)- 97) performed between January 2005 and December 2015 by fellowship trained foot and ankle surgeons in a single institution. Based on preoperative deformity (AAA- 28 degree valgus to 26 degrees varus; OAA- 41 degree valgus to 28 degree varus), they were subdivided into 2 groups based upon deformity more than 15 degrees. Union rates, time to union, length of hospital stay and patient related factors like smoking, alcoholism, diabetes, BMI were assessed.

Mean age of patients was 60 years (Range 20 to 82 years)(Male:Female-87:32). Overall fusion rate was 93% in AAA and 89% in OAA (p=0.4). On sub group analysis of influence of preoperative deformity, there was no difference in union rates of AAA versus OAA. 7 patients in AAA and 3 in OAA required further procedures. Average time to union was 13.7 in AAA and 12.5 weeks in OAA (p=0.3). Average hospital stay was 2.6 days in AAA and 3.8 days in OAA (p=0.003). Smoking, alcoholism, Diabetes, BMI did not have any correlation with union rates. Although both AAA and OAA showed good union rates, hospital stay was significantly shorter in AAA. A larger deformity did not adversely affect union rates in AAA. Time to union was higher in AAA though it was statistically insignificant. Lifestyle risk factors did not have cumulative effect on union.

We conclude that AAA is a reproducible method of treating end stage tibiotalar arthritis irrespective of preoperative deformity and patient related factors.

We report the early results of a patello-femoral prosthesis with a more anatomical trochlear component than previously reported designs, and with a patella component, geometry and instrumentation that allows optimum tracking and coverage of the patella, prior to final fixation of the patella component.

The first 115 patello-femoral prostheses were implanted between April 2000 and October 2005, and were followed up in a Special Clinic by one observer, who was not the operating surgeon, using the Bristol Knee Score (BKS), and the Oxford Knee Score (OKS). 115 patello-femoral arthroplasties were performed in 86 patients, 28 bilateral procedures (24.3%). 20 (71%) of which were performed as a single procedure. There were 100 females and 15 males, a ratio of 6.6:1, with a mean age of 70.05 years. (range 57 – 79). There were 9 patients lost to follow up, giving a follow up rate of 89%. The mean period follow up was 36 months (range 12 – 78 months). The median OKS (maximum 12/60) was 40/60 pre-operatively (range 22-46) and 22/60 Post-operatively (range 12 – 38), and the BKS was 45 pre-operatively (range 35 – 65) and 85 post-operatively (range 55 – 100). The mean range of movement was 110° pre-operatively (range 90 – 120°), and 125° (range 90 – 130°) post-operatively.

There was 1 superficial wound infection. 2 knees were revised to total knee replacement for progression of arthritis. Four other patients had re-operations, 1 for bilateral subluxing patellae, 2 for soft tissue problems, 1 patient had a locked knee with displacement of the patella prosthesis, which was revised successfully.

Early results of the FPV prosthesis demonstrate, like other more recent designs, that there are fewer problems with mal alignment and mal tracking than with earlier prosthesis, giving 90% good or excellent results.

Introduction

Pre-operative urine screening is accepted practice during pre-operative assessment in elective orthopaedic practice. There is no evidence surrounding the benefits, effects or clinical outcomes of such a practice.